← Back to catalogue

NeuroBlate Optic FullFire® Laser Probe

FDA UDI

Class II (US FDA UDI)

by Monteris Medical Corp

Identity

Trade Name
NeuroBlate Optic FullFire® Laser Probe FDA UDI
Generic Name
MRI-guided laser interstitial thermal therapy system beam guide FDA UDI
Device Name
3.3mm Diffusing Tip Laser Probe FDA UDI
Model / Reference
20893-1 FDA UDI
Description
3.3mm Diffusing Tip Laser Probe FDA UDI

Identifiers

Catalog Number
DTP-101-01 FDA UDI
Primary DI / UDI-DI
00816589020960 FDA UDI
FDA Product Code
GEX FDA UDI
GMDN Term
MRI-guided laser interstitial thermal therapy system beam guide FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
878.4810 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI
MRI Safety
MR Conditional FDA UDI

Dimensions & Sizes

Size
Outer Diameter — 3.3 Millimeter FDA UDI

Category: MRI-guided laser interstitial thermal therapy system beam guide

NeuroBlate Optic FullFire® Laser Probe by Monteris Medical Corp — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as MRI-guided laser interstitial thermal therapy system beam guide.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Monteris Medical Corp

Sources (1)

  • FDA UDI 90f8e349-0507-48df-8c4b-ad6f2fe79e8c 36 fields · synced May 30, 2026